يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"CTLA-4, cytotoxic T lymphocyte-associated antigen-4"', وقت الاستعلام: 1.15s تنقيح النتائج
  1. 1

    المساهمون: Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Département de Pathologie [AP-HP Hôpital Européen Georges Pompidou], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)

    المصدر: JACC. CardioOncology, Vol 2, Iss 3, Pp 511-514 (2020)
    JACC: CardioOncology
    JACC: CardioOncology, Elsevier, 2020, 2 (3), pp.511-514. ⟨10.1016/j.jaccao.2020.05.022⟩

  2. 2
  3. 3

    المصدر: Acta Pharmaceutica Sinica. B
    Acta Pharmaceutica Sinica B, Vol 11, Iss 1, Pp 13-29 (2021)

    مصطلحات موضوعية: PDAC, pancreatic ductal adenocarcinoma, STAT, signal transducers and activators of transcription, RAS, rat sarcoma protein, Protein tyrosine phosphatase, Review, TIGIT, T-cell immunoglobulin and ITIM domain protein, SCC, squamous cell carcinoma, B-ALL, B-cell acute lymphoblastic leukemia, SCNA, somatic copy number change, 0302 clinical medicine, KRAS, v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, Selectivity, CTLA-4, cytotoxic T lymphocyte-associated antigen-4, General Pharmacology, Toxicology and Pharmaceutics, Tyrosine, GAB2, Grb2-associated binding protein-2, PD-1/PDL-1, programmed cell death protein-1/programmed death ligand-1, AML, acute myeloid leukemia, 0303 health sciences, PTK, protein tyrosine kinase, Chemistry, SHP2, Src homology containing protein tyrosine phosphatase 2, TKIs, tyrosine kinase inhibitors, 030220 oncology & carcinogenesis, Tumor therapy, JAK, Janus kinase, BTLA, B and T lymphocyte attenuator, PTP, protein tyrosine phosphatase, RTKs, receptor tyrosine kinase inhibitors, Proto-oncogene tyrosine-protein kinase Src, Allosteric inhibitor, Phosphatase, Allosteric regulation, CSF-1, colony stimulating factor-1, Tumor targeted, 03 medical and health sciences, PI3K, phosphatidylinositol 3 kinase, TYROSINE PHOSPHATASE SHP2, SAR, structure–activity relationship, ERK1/2, extracelluar signal-regulated kinase 1/2, SBDD, structure-based drug design, GRB2, growth factor receptor-bound protein 2, PDX, patient-derived xenograft, 030304 developmental biology, FLT3, Fms-like tyrosine kinase-3, ALK, anaplastic lymphoma kinase, lcsh:RM1-950, Bioavailability, EGFR, epidermal growth factor receptor, CADD, computer aided drug design, lcsh:Therapeutics. Pharmacology, HGF/SF, hepatocyte growth factor/scatter factor, NLRP3, NLR family, pyrin domain containing protein 3, HER2, human epidermal growth factor receptor-2, Cancer research, SHP2, MAPK, mitogen-activated protein kinase, hERG, human ether-a-go-go-related gene

  4. 4
  5. 5